PROTEASOMINHIBITOREN

Patent europeic · EP2212334 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2212334
Numer da la dumonda
EP07839608
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-10-2007
Publitgà
04-08-2010
Concedì
15-08-2012
La protecziun finescha il pli tard
15-10-2027
Proxima taxa annuala scadenta
31-10-2026
Classas IPC
C07F 5/02 (2006.01)
C07K 5/04 (2006.01)
C07K 5/06 (2006.01)
A61K 38/06 (2006.01)
A61K 38/04 (2006.01)
Dumonda PCT
PCT/US2007/022079 16.10.2007
Publicaziun PCT
WO2009/051581 23.04.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-11-2025

    Midada

    Published in Swissreg on 01.11.2025

  2. 01-11-2024

    Midada

    Published in Swissreg on 01.11.2024

  3. 01-11-2023

    Midada

    Published in Swissreg on 01.11.2023

  4. 01-11-2022

    Midada

    Published in Swissreg on 01.11.2022

  5. 16-08-2012

    Represchentant inscrit

    Representative
    Kirker & Cie S.A., 122, rue de Genève, Case postale 90, 1226 Geneve-Thônex

    Published in Swissreg on 16.08.2012

  6. 15-08-2012

    Concedì

    Published in Swissreg on 15.08.2012

Partidas

Possessur

Millennium Pharmaceuticals, Inc.

40 Landsdowne Street, Cambridge, MA 02139, US

Represchentant

Kirker & Cie SA

Kirker & Cie S.A.

122, rue de Genève Case postale 90, 1226 Geneve-Thônex

Inventur

OLHAVA, Edward, J.

Newton MA 02460, US

DANCA, Miheala, D.

Mendham NJ 07945, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.